Deep Dive
Let's Talk Risk! Podcast
Deep Dive: When Patient Preference Becomes Regulatory Evidence
- Published
- August 28, 2026
- Duration
- 32:10
- Summary source
- description
- Last updated
- Sep 9, 2026
Discusses Patient preference is no longer a soft qualitative afterthought.What if a device carries significant…
Summary
Patient preference is no longer a soft qualitative afterthought.What if a device carries significant risks, but patients are willing to accept them for a meaningful clinical benefit?This Deep Dive examines how FDA’s evolving approach to Patient Preference Information (PPI) can turn those tradeoffs into quantitative evidence for regulatory benefit-risk dec…
Intelligent Report
Sign in to read teasers, or upgrade to Research Pro to commission intelligent report for this episode. Learn more →
Show notes
Patient preference is no longer a soft qualitative afterthought.What if a device carries significant risks, but patients are willing to accept them for a meaningful clinical benefit?This Deep Dive examines how FDA’s evolving approach to Patient Preference Information (PPI) can turn those tradeoffs into quantitative evidence for regulatory benefit-risk decisions.Key highlights covered in the audio:* PPI is not the same as a patient-reported outcome. PROs describe what patients experience. PPI ask